The Cholangiocarcinoma Foundation and Komodo Health announced an agreement linking a cancer advocacy group with a healthcare analytics and insights delivery company to advance the treatment of cholangiocarcinoma.
With major leadership changes, grant disruptions and terminations, and a stoked distrust in science, Steven Artandi, the director of Stanford Cancer Center, worries that young investigators will feel disenchanted by the U.S. research atmosphere and take their work and study elsewhere.
